# Chemotherapy > Citation bundle for Chemotherapy on The Treatment Registry. > URL: https://thetreatmentregistry.com/procedures/chemotherapy > Bundle URL: https://thetreatmentregistry.com/api/citations/procedures/chemotherapy - Category: oncology - Average recovery: 21 days - Typical sessions: 6 - Price range (USD international): $5,000–$30,000 ## Description Chemotherapy is the systemic delivery of cytotoxic drugs to kill or slow the growth of cancer cells. The term spans many drug classes — alkylating agents, antimetabolites, antimicrotubule agents, topoisomerase inhibitors, anthracyclines and others — and many delivery routes (intravenous, oral, intrathecal, intra-arterial). Regimens are typically defined by cancer type, stage, and patient fitness, and are delivered as a sequence of cycles with rest periods to allow normal tissues to recover. Modern oncology increasingly combines cytotoxic chemotherapy with targeted therapies, immunotherapies, hormonal agents, and radiotherapy in carefully sequenced protocols. Travelling abroad for chemotherapy is uncommon and should be considered cautiously: continuity of care across cycles, access to emergency services for febrile neutropenia, and integration with home-country surveillance imaging are easier to manage when treatment is delivered close to where the patient lives. ## Overview Chemotherapy is a systemic cancer treatment that uses one or more cytotoxic drugs to destroy rapidly dividing cells throughout the body. It may be used as a primary treatment, in combination with surgery or radiotherapy, or as palliative care to control disease progression. Treatment is organised in cycles — a period of drug administration followed by a rest period — with most protocols spanning three to six months. Candidacy depends on the type and stage of cancer, the patient's overall fitness, organ function, and prior treatment history. Not all cancers respond equally to chemotherapy; haematological malignancies and testicular cancer tend to be highly chemo-sensitive, while other solid tumours may require combination approaches. Some patients seek chemotherapy abroad to access specific drugs that are unavailable, prohibitively expensive, or subject to long waiting lists in their home country. The treatment experience varies considerably by regimen. Some protocols involve brief outpatient infusions with manageable side effects, while others require multi-day inpatient admissions and intensive supportive care. Patients should understand that outcomes depend heavily on the quality of the treating institution's oncology infrastructure, laboratory monitoring capabilities, and access to emergency care for complications such as febrile neutropenia. Chemotherapy drugs fall into several broad classes, each targeting different mechanisms of cell division. Alkylating agents damage DNA directly, antimetabolites interfere with DNA and RNA synthesis, and taxanes disrupt the mitotic spindle. Newer targeted agents — including monoclonal antibodies and tyrosine kinase inhibitors — act on specific molecular pathways driving tumour growth, offering improved selectivity but at substantially higher cost. Combination regimens using drugs from different classes are standard practice for most cancers, designed to attack tumour cells through multiple mechanisms and reduce the likelihood of resistance. The choice of protocol is guided by tumour histology, molecular profiling, clinical staging, and published evidence from randomised controlled trials. ## Peer-reviewed outcome rates - **Complication rate:** 30.00% (range 20.00–50.00%) — from 1 cited source ## Common risks - Nausea and vomiting - Hair loss - Immunosuppression and infection risk - Fatigue - Organ toxicity (cardiac, renal, hepatic) - Neuropathy ## FAQs ### Will I lose my hair during chemotherapy? Hair loss depends on the specific drugs used. Some regimens cause complete hair loss, others cause thinning, and some cause none at all. Hair typically begins to fall out one to three weeks after the first treatment and regrows within two to three months of completing chemotherapy. ### Can I work during chemotherapy? Many patients continue working during chemotherapy, particularly in less physically demanding roles. The ability to work depends on the regimen's intensity, the individual's response, and the nature of the job. Planning around the nadir period — when fatigue and infection risk peak — is advisable. ### What should I eat during chemotherapy? A varied, nutritious diet is important to maintain strength and support immune function. Nausea may limit appetite, and a dietitian can advise on strategies to maintain adequate intake. High-risk foods such as raw meat, unpasteurised dairy, and unwashed produce should be avoided during immunosuppressed periods. ### How do I know if chemotherapy is working? Response to chemotherapy is assessed through regular imaging — CT scans, PET scans, or MRI — and blood tumour markers if applicable. These are typically performed after two to three cycles to determine whether the regimen is achieving the intended response. The treating oncologist will discuss findings and adjust the plan if necessary. ### What is febrile neutropenia and why is it serious? Febrile neutropenia occurs when chemotherapy reduces white blood cell counts to critically low levels and an infection develops, causing fever. Because the immune system cannot mount a normal response, this can progress rapidly to life-threatening sepsis. It requires emergency hospitalisation and prompt intravenous antibiotics. ### Are the side effects of chemotherapy permanent? Most side effects — including nausea, fatigue, and hair loss — are temporary and resolve after treatment ends. Some drugs carry a risk of longer-lasting or permanent effects, including peripheral neuropathy (tingling or numbness in the hands and feet), cardiac effects with certain agents, and in rare cases, secondary malignancies. ### Can I travel during chemotherapy? Travel is generally best avoided during the nadir period when infection risk is highest. Short trips between cycles may be feasible when blood counts have recovered, but patients should carry medical records, have access to emergency care at the destination, and avoid crowded public spaces and sick contacts. ### What is the difference between chemotherapy and immunotherapy? Chemotherapy directly kills rapidly dividing cells using cytotoxic drugs. Immunotherapy works differently — it activates or modulates the patient's own immune system to recognise and attack cancer cells. Many patients now receive combinations of both approaches, and immunotherapy has dramatically improved outcomes for certain cancers including melanoma and lung cancer. ## Alternative treatments - **Immunotherapy (checkpoint inhibitors)** — Replacing or adjuncting chemo in many cancers; very tumor-type-specific. - **Targeted therapy** — When the tumour expresses a druggable mutation; can be more effective and less toxic. - **Radiation therapy** — Local-control alternative when systemic spread is not the primary concern. - **Best supportive care** — When treatment goals are palliative and quality-of-life is the priority. ## Sources - [ESMO — Clinical Practice Guidelines](https://www.esmo.org/guidelines) — European Society for Medical Oncology (accessed 2026-05-09) - [ASCO/ONS Chemotherapy Administration Safety Standards](https://ascopubs.org/doi/10.1200/JOP.2016.017905) — American Society of Clinical Oncology (accessed 2026-05-09) - [NCCN Clinical Practice Guidelines in Oncology](https://www.nccn.org/guidelines/category_1) — National Comprehensive Cancer Network (accessed 2026-06-29)